In multiple models of neurodegenerative disease such as Alzheimer’s and Parkinson’s Diseases, inhibition of mTOR phosphorylation by rapamycin is correlated with improved neuronal viability [10], [34], [35]. This evidence concerns the gene MTOR and neurodegenerative disease.